ACS Chem Neurosci manuscript!


As a collaborative work of several laboratories, lead by A. Kozikowski, StarWise Therapeutics, USA, we published a manuscript detailing the development and functional characterization of SW-100, a brain penetrable inhibitor of histone deacetylase 6. Using a mouse model of the Fragile X syndrome, we showed that SW-100 ameliorates several memory and learning impairments associated with this disease. Congratulation to all co-authors!